Zoetis Company Profile (NYSE:ZTS)

About Zoetis

Zoetis logoZoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: ZTS
  • CUSIP: 98978V10
Key Metrics:
  • Previous Close: $53.47
  • 50 Day Moving Average: $54.35
  • 200 Day Moving Average: $51.80
  • 52-Week Range: $39.35 - $56.50
  • Trailing P/E Ratio: 32.41
  • Foreward P/E Ratio: 20.18
  • P/E Growth: 1.72
  • Market Cap: $26.31B
  • Outstanding Shares: 491,964,000
  • Beta: 1.07
Profitability:
  • Net Margins: 14.10%
  • Return on Equity: 72.96%
  • Return on Assets: 12.51%
Debt:
  • Debt-to-Equity Ratio: 2.80%
  • Current Ratio: 3.24%
  • Quick Ratio: 1.73%
Additional Links:
Companies Related to Zoetis:

Analyst Ratings

Consensus Ratings for Zoetis (NYSE:ZTS) (?)
Ratings Breakdown: 3 Sell Ratings, 3 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Hold (Score: 2.47)
Consensus Price Target: $56.40 (5.48% upside)

Analysts' Ratings History for Zoetis (NYSE:ZTS)
Show:
DateFirmActionRatingPrice TargetDetails
2/19/2017BMO Capital MarketsReiterated RatingOutperform$60.00View Rating Details
2/16/2017GuggenheimBoost Price TargetBuy$60.00 -> $65.00View Rating Details
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00View Rating Details
1/20/2017Jefferies Group LLCBoost Price TargetBuy$62.00 -> $64.00View Rating Details
12/20/2016Deutsche Bank AGInitiated CoverageBuy$62.00View Rating Details
12/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$61.00View Rating Details
12/15/2016Cowen and CompanyUpgradeMarket Perform -> Outperform$50.00 -> $60.00View Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$53.00View Rating Details
10/12/2016Stifel NicolausReiterated RatingBuy$58.00View Rating Details
9/29/2016Bank of America CorpInitiated CoverageBuy$60.00View Rating Details
9/9/2016ArgusBoost Price TargetBelow Average$54.00 -> $58.00View Rating Details
9/7/2016Credit Suisse GroupReiterated RatingFocus List$60.00View Rating Details
8/4/2016Citigroup Inc.Boost Price TargetNeutral$50.00 -> $53.00View Rating Details
8/4/2016Barclays PLCBoost Price TargetEqual Weight$45.00 -> $49.00View Rating Details
5/6/2016Goldman Sachs Group, Inc. (The)DowngradeNeutral -> Sell$46.00 -> $48.00View Rating Details
1/8/2016Cleveland ResearchInitiated CoverageBuyView Rating Details
8/6/2015William BlairUpgradeMarket Perform -> OutperformView Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Zoetis (NYSE:ZTS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017        
2/16/2017Q416$0.45$0.47$1.28 billion$1.30 billionViewN/AView Earnings Details
11/2/2016Q316$0.46$0.52$1.22 billion$1.20 billionViewN/AView Earnings Details
8/3/2016Q216$0.44$0.49$1.17 billion$1.20 billionViewN/AView Earnings Details
5/4/2016Q116$0.41$0.48$1.10 billion$1.20 billionViewN/AView Earnings Details
2/16/2016Q415$0.39$0.43$1.25 billion$1.30 billionViewListenView Earnings Details
11/3/2015Q315$0.40$0.50$1.18 billion$1.20 billionViewN/AView Earnings Details
8/4/2015Q215$0.38$0.43$1.12 billion$1.20 billionViewN/AView Earnings Details
5/5/2015Q115$0.37$0.41$1.11 billion$1.10 billionViewN/AView Earnings Details
2/11/2015Q414$0.36$0.40$1.27 billion$1.30 billionViewN/AView Earnings Details
11/4/2014Q314$0.37$0.41$1.16 billion$1.20 billionViewN/AView Earnings Details
5/6/2014Q114$0.37$0.38$1.13 billion$1.10 billionViewN/AView Earnings Details
2/11/2014Q413$0.34$0.36$1.21 billion$1.25 billionViewN/AView Earnings Details
11/5/2013Q313$0.34$0.34$1.07 billion$1.10 billionViewN/AView Earnings Details
8/6/2013Q2 2013$0.36$0.36$1.13 billion$1.11 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.27$0.36$1.24 billion$1.09 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zoetis (NYSE:ZTS)
Current Year EPS Consensus Estimate: $2.32 EPS
Next Year EPS Consensus Estimate: $2.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.40$0.41$0.41
Q2 20162$0.44$0.45$0.45
Q3 20162$0.46$0.46$0.46
Q4 20161$0.46$0.46$0.46
Q1 20171$0.52$0.52$0.52
Q2 20171$0.56$0.56$0.56
Q3 20171$0.62$0.62$0.62
Q4 20171$0.59$0.59$0.59
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Zoetis (NYSE:ZTS)
Annual Dividend:$0.42
Dividend Yield:0.79%
Dividend Growth:24.90% (3 Year Average)
Payout Ratio:30.44% (Based on Trailing 12 Months of Earnings)
18.10% (Based on Current Year Consensus EPS Estimate)
15.85% (Based on Next Year Consensus EPS Estimate)
Track Record:3 Years of Consecutive Dividend Growth

Dividend History for Zoetis (NYSE:ZTS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2017quarterly$0.110.76%4/4/20174/6/20176/1/2017
12/6/2016quarterly$0.110.82%1/18/20171/20/20173/1/2017
10/7/2016quarterly$0.100.73%11/1/201611/3/201612/1/2016
5/13/2016quarterly$0.100.82%6/28/20166/30/20168/30/2016
2/22/2016quarterly$0.100.89%4/5/20164/7/20166/1/2016
12/17/2015quarterly$0.100.81%1/19/20161/21/20163/1/2016
10/2/2015quarterly$0.080.77%11/3/201511/5/201512/1/2015
7/22/2015quarterly$0.080.66%8/11/20158/13/20159/1/2015
3/2/2015quarterly$0.080.7%4/7/20154/9/20156/2/2015
12/18/2014quarterly$0.080.77%1/20/20151/22/20153/3/2015
10/2/2014quarterly$0.070.76%11/3/201411/5/201412/2/2014
7/31/2014quarterly$0.070.88%8/18/20148/20/20149/2/2014
3/26/2014quarterly$0.070.98%4/23/20144/27/20146/2/2014
12/19/2013quarterly$0.070.89%1/28/20141/30/20143/4/2014
9/12/2013quarterly$0.070.84%10/30/201311/1/201312/2/2013
6/20/2013quarterly$0.078/1/20139/2/2013
3/29/2013special$0.074/29/20135/1/20136/6/2013
3/28/2013quarterly$0.075/1/20136/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Zoetis (NYSE:ZTS)
Insider Ownership Percentage: 0.05%
Institutional Ownership Percentage: 94.54%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2016Kristin C PeckInsiderSell10,092$49.55$500,058.60View SEC Filing  
11/8/2016Roxanne LaganoInsiderSell9,797$50.43$494,062.71View SEC Filing  
9/6/2016Michael B MccallisterDirectorBuy2,000$51.34$102,680.00View SEC Filing  
9/2/2016Andrew FentonInsiderSell13,870$51.25$710,837.50View SEC Filing  
9/1/2016Heidi C ChenInsiderSell32,097$50.98$1,636,305.06View SEC Filing  
5/9/2016Pershing Square Capital ManageDirectorSell16,850,000$46.55$784,367,500.00View SEC Filing  
8/8/2013Michael MccallisterDirectorBuy7,000$31.35$219,450.00View SEC Filing  
2/6/2013Frank A DamelioDirectorBuy5,000$26.00$130,000.00View SEC Filing  
2/6/2013Sandra J BeatyEVPBuy2,000$26.00$52,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Zoetis (NYSE:ZTS)
DateHeadline
News IconThe Technicals For Zoetis Inc. (ZTS) Have Been Dissected (Brutally) - NY Stock News (NYSE:ZTS)
nystocknews.com - February 21 at 4:22 PM
News IconRevenue Approximations Analysis: Zoetis Inc. (ZTS), AbbVie Inc. (ABBV) - StockNewsJournal (NYSE:ZTS)
stocknewsjournal.com - February 21 at 4:22 PM
finance.yahoo.com logoDrug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS (NYSE:ZTS)
finance.yahoo.com - February 20 at 8:00 AM
News IconDrilling Down Into the Charts for Zoetis Inc. (ZTS) - The USA Commerce (NYSE:ZTS)
www.theusacommerce.com - February 19 at 8:01 AM
News IconAnalysts Watch Zoetis Inc. (NYSE:ZTS) And Issue New Targets (NYSE:ZTS)
latribunadecanarias.com - February 17 at 9:41 AM
seekingalpha.com logoZoetis (ZTS) Q4 2016 Results - Earnings Call Transcript (NYSE:ZTS)
seekingalpha.com - February 17 at 9:41 AM
News IconWill Zoetis Inc. (NYSE:ZTS) be growing after Earnings Report? (NYSE:ZTS)
mundoaguaysaneamiento.net - February 17 at 9:41 AM
News IconZoetis Inc. (ZTS) to Release Earnings on Thursday (NYSE:ZTS)
hoyentv.com - February 17 at 9:41 AM
us.rd.yahoo.com logo7:05 am Zoetis beats by $0.01, reports revs in-line; slightly lowers FY17 EPS and revenue guidance, in-line (NYSE:ZTS)
us.rd.yahoo.com - February 17 at 9:41 AM
biz.yahoo.com logoQ4 2016 Zoetis Inc Earnings Release - Before Market Open (NYSE:ZTS)
us.rd.yahoo.com - February 17 at 9:41 AM
sg.finance.yahoo.com logoZoetis tops 4Q profit forecasts (NYSE:ZTS)
us.rd.yahoo.com - February 17 at 9:41 AM
us.rd.yahoo.com logoZoetis (ZTS) Tops on Earnings in Q4, Updates View (NYSE:ZTS)
us.rd.yahoo.com - February 17 at 9:41 AM
us.rd.yahoo.com logoEdited Transcript of ZTS earnings conference call or presentation 16-Feb-17 1:30pm GMT (NYSE:ZTS)
us.rd.yahoo.com - February 17 at 9:41 AM
finance.yahoo.com logoZoetis to Participate in the Cowen and Company 37th Annual Health Care Conference (NYSE:ZTS)
finance.yahoo.com - February 17 at 9:41 AM
seekingalpha.com logoZoetis earnings up 142%; non-GAAP EPS up 11% in FY16; updates 2017 guidance (NYSE:ZTS)
seekingalpha.com - February 16 at 10:34 AM
News IconShares of Zoetis Inc. (ZTS) Sees Large Inflow of Net Money Flow (NYSE:ZTS)
fairydetox.org - February 15 at 7:06 AM
4-traders.com logoZoetis Inc. (NYSE:ZTS) Files An 8-K Regulation FD Disclosure (NYSE:ZTS)
www.4-traders.com - February 15 at 7:06 AM
News IconZoetis Inc. (NYSE:ZTS) Insiders Move Reflect Future Prospects (NYSE:ZTS)
mundoaguaysaneamiento.net - February 15 at 7:06 AM
finance.yahoo.com logoZoetis Declares Second Quarter 2017 Dividend (NYSE:ZTS)
finance.yahoo.com - February 15 at 7:06 AM
biz.yahoo.com logoZOETIS INC. Files SEC form 8-K, Regulation FD Disclosure (NYSE:ZTS)
biz.yahoo.com - February 15 at 7:06 AM
4-traders.com logoZoetis Inc : annual earnings release (NYSE:ZTS)
www.4-traders.com - February 14 at 7:17 AM
thestreet.com logoUse Pullback on Zoetis to Do Some Buying (NYSE:ZTS)
realmoney.thestreet.com - February 14 at 7:17 AM
nasdaq.com logoWill Zoetis (ZTS) Disappoint Estimates This Earnings Season? - Nasdaq (NYSE:ZTS)
www.nasdaq.com - February 11 at 6:56 AM
News IconThe Valeant Pharmaceuticals International, Inc. (VRX) Position Reduced by BloombergSen Inc (NYSE:ZTS)
nyhetsbanken.info - February 9 at 6:53 AM
News IconWhy to Keeping Eye on Zoetis Inc. (ZTS), Colgate-Palmolive Company (CL)? - StockNewsJournal (NYSE:ZTS)
stocknewsjournal.com - February 8 at 2:23 AM
News IconChanges to Broker Targets on: Zoetis Inc (NYSE:ZTS) - Post Registrar (NYSE:ZTS)
postregistrar.com - February 8 at 2:23 AM
News IconTop Gainers of the Day: Zoetis Inc. (NYSE:ZTS) from Drugs – Generic (NYSE:ZTS)
twincountynews.com - February 7 at 4:20 PM
finance.yahoo.com logoBMO Asset Management to Launch New ETFs on NEO (NYSE:ZTS)
finance.yahoo.com - February 7 at 4:20 PM
News IconStock Price of Zoetis Inc. (ZTS) Increases 2.32% - Morning Outlook (NYSE:ZTS)
www.morningoutlook.com - February 7 at 6:28 AM
News IconLeading stocks in today’s market: Zoetis Inc. (NYSE:ZTS) (NYSE:ZTS)
twincountynews.com - February 5 at 6:10 AM
News IconStocks Luring Investors with Juicy Profitability Figures: Zoetis Inc. (NYSE:ZTS), Tesaro, Inc. (NASDAQ:TSRO) - Street Wise Report (press release) (blog) (NYSE:ZTS)
streetwisereport.com - February 1 at 7:38 AM
News IconEarnings Forecast Research on Zoetis Inc. (ZTS) - Highland Mirror (NYSE:ZTS)
www.highlandmirror.com - February 1 at 7:38 AM
News IconStock Watch: Focusing in on Zoetis Inc. (NYSE:ZTS) - Gilbert Daily (NYSE:ZTS)
gilbertdaily.com - January 29 at 7:22 AM
News IconEarnings in Full Force, Analysts Take Aim at Zoetis Inc. (NYSE:ZTS) - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 27 at 6:57 AM
istreetwire.com logoStocks in the Spotlight: Exact Sciences Corporation (EXAS), Zoetis Inc. (ZTS), Avon Products, Inc. (AVP) - iStreetWire (NYSE:ZTS)
istreetwire.com - January 24 at 9:05 PM
News IconAre Analysts Predicting a Near-Term Upswing For Zoetis Inc. (NYSE:ZTS)? - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 24 at 9:05 PM
bizjournals.com logoTechnical Reports on Generic Drugs Stocks -- Zoetis, Mallinckrodt, Akorn, and Diplomat Pharmacy (NYSE:ZTS)
www.bizjournals.com - January 24 at 4:03 PM
News IconZoetis Inc. (ZTS) Given New $64.00 Price Target at Jefferies Group (NYSE:ZTS)
xboxonezone.com - January 24 at 4:03 PM
News IconZoetis Inc. (NYSE:ZTS) declared dividend of $0.105 per share (NYSE:ZTS)
prensariotiretail.com - January 24 at 4:03 PM
forbes.com logoFirst Week of March 17th Options Trading For Zoetis (NYSE:ZTS)
www.forbes.com - January 24 at 11:59 AM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Zoetis Inc. (NYSE:ZTS) - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 22 at 8:32 AM
realistinvestor.com logoQuarterly Deferred Tax Assets Of Zoetis Inc. (NYSE:ZTS) At $127 Millions - RealistInvestor.com (NYSE:ZTS)
www.realistinvestor.com - January 22 at 8:32 AM
News IconWill The Needle Move For Zoetis Inc. (NYSE:ZTS) Shares This Earnings Season? - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 19 at 8:15 AM
seekingalpha.com logoZoetis goes ex-dividend today (NYSE:ZTS)
seekingalpha.com - January 18 at 7:03 AM
News IconStocks Rallying on Investment Valuation: Synergy Pharmaceuticals (NASDAQ:SGYP), Zoetis (NYSE:ZTS) - Street Wise Report (press release) (blog) (NYSE:ZTS)
streetwisereport.com - January 18 at 6:35 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on Zoetis Inc. (NYSE:ZTS) - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 18 at 6:35 AM
News IconFirms & Funds Reinforcing Their Perception of Zoetis Inc. (NYSE:ZTS) - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 18 at 6:35 AM
nasdaq.com logoZoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 18, 2017 ... - Nasdaq (NYSE:ZTS)
www.nasdaq.com - January 18 at 6:35 AM
News IconFocus Equity: Stock Strength Indicator Update on Zoetis Inc. (NYSE:ZTS) - Wall Street Beacon (NYSE:ZTS)
wsbeacon.com - January 16 at 9:22 AM
investopedia.com logoZoetis Stock Trades Ex-Dividend Wednesday (ZTS) (NYSE:ZTS)
www.investopedia.com - January 15 at 10:12 PM

Social

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis announced a quarterly dividend on Wednesday, February 15th. Stockholders of record on Thursday, April 6th will be given a dividend of $0.105 per share on Thursday, June 1st. This represents a $0.42 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Tuesday, April 4th.

Where is Zoetis' stock going? Where will Zoetis' stock price be in 2017?

15 analysts have issued twelve-month price targets for Zoetis' stock. Their forecasts range from $35.00 to $65.00. On average, they expect Zoetis' share price to reach $56.40 in the next year.

When will Zoetis announce their earnings?

Zoetis is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.

What are analysts saying about Zoetis stock?

Here are some recent quotes from research analysts about Zoetis stock:

  • Guggenheim analysts commented, "We are raising our PT for ZTS shares after a 4Q beat and a lower than expected FX headwind for '17. The increase in our PT is driven by multiple expansion. We arrive at our new PT by using a DCF analysis. ZTS's solid execution this quarter increases our confidence that it can exceed consensus expectations for '17+ and sustain its 21x forward P/E multiple. Upward earnings revisions could come from margin expansion, M&A, and launches. Therefore, the sell-off today, which we think is motivated by profit taking, is overdone, in our view. We believe the weakness (ZTS down 3% vs. S&P down 0.14%) presents a good buying opportunity for the stock." (2/16/2017)
  • According to Zacks Investment Research, "Performance of Zoetis’ livestock business has been disappointing. Other headwinds include disease outbreaks and stiff competition in the animal health space. While disease outbreak among animals is a material cause of concern for Zoetis’ livestock products, the company continued to witness a decline in the U.S. sales of swine products in the third quarter of 2016 due to increased competition. Competitive pressures could adversely affect the company’s growth prospects. Pipeline setbacks are another major concern. Particularly, development and regulatory setbacks for late-stage pipeline candidates would be a major disappointment for the company. However, Zoetis’ companion animal business should continue to perform well. Further, its efforts on boosting operational efficiency bode well. Shares of Zoetis have outperformed the industry in the past one year. Estimates have been stable ahead of the company's Q4 results." (1/17/2017)

Who owns Zoetis stock?

Zoetis' stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (4.10%), Marshall Wace LLP (1.68%), Janus Capital Management LLC (1.19%), DSM Capital Partners LLC (0.99%), William Blair Investment Management LLC (0.94%) and Frontier Capital Management Co. LLC (0.45%). Company insiders that own Zoetis stock include Andrew Fenton, Heidi C Chen, Kristin C Peck, Michael B Mccallister, Pershing Square Capital Manage and Roxanne Lagano.

Who sold Zoetis stock? Who is selling Zoetis stock?

Zoetis' stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Calamos Advisors LLC, Renaissance Technologies LLC, Janus Capital Management LLC, William Blair Investment Management LLC, Van ECK Associates Corp, BP PLC and Employees Retirement System of Texas. Company insiders that have sold Zoetis stock in the last year include Andrew Fenton, Heidi C Chen, Kristin C Peck, Pershing Square Capital Manage and Roxanne Lagano.

Who bought Zoetis stock? Who is buying Zoetis stock?

Zoetis' stock was bought by a variety of institutional investors in the last quarter, including DSM Capital Partners LLC, State Street Corp, Asset Management One Co. Ltd., Russell Investments Group Ltd., AMF Pensionsforsakring AB, Frontier Capital Management Co. LLC, Bodenholm Capital AB and Atlanta Capital Management Co. L L C.

How do I buy Zoetis stock?

Shares of Zoetis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Zoetis stock cost?

One share of Zoetis stock can currently be purchased for approximately $53.47.

Zoetis (NYSE:ZTS) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Earnings History Chart

Earnings by Quarter for Zoetis (NYSE:ZTS)

Dividend History Chart

Dividend Payments by Quarter for Zoetis (NYSE:ZTS)

Last Updated on 2/22/2017 by MarketBeat.com Staff